Aktienanalyse zu Nephros Inc (NEPH)NEPHNephros Inc

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate. It operates in the Industrials sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Nephros Inc is currently not a strong buy due to its low RSI of 16.83, indicating oversold conditions, and a significant 40.36% year-to-date decline. While the company reported record revenue of $6 million in Q2 2026 and a net income increase of over 400% to approximately $1.2 million, the stock's recent performance has been poor, with a 10.63% drop over the last five days. The main risk is its high debt to equity ratio of 6.17%, which could impact financial stability.